Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis

Launched by NIGDE OMER HALISDEMIR UNIVERSITY · Aug 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of two specific eating patterns—intermittent fasting and the Mediterranean diet—on women with Multiple Sclerosis (MS). The researchers want to find out how these diets might improve quality of life, sleep, and hormone levels related to appetite in MS patients. This is important because, so far, there hasn’t been any research comparing these two diets in relation to these factors in people with MS.

To participate in this study, women need to be between 18 and 65 years old and have a confirmed diagnosis of MS. They should not be experiencing an MS attack, should not be in menopause, and must not have any other autoimmune diseases or serious health conditions. Participants will need to sign a consent form and undergo a brain MRI within the last three months. Throughout the study, they will follow either the intermittent fasting or Mediterranean diet and share their experiences. It's an exciting opportunity for eligible women to explore how these dietary approaches may help manage their condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • To apply to the neurology outpatient clinic, to be a female between the ages of 18-65 who has been diagnosed with MS by a physician
• • Not being in the attack period
• • Not being in menopause Not being diagnosed with any autoimmune system disease other than -MS that may adversely affect the study,
• • Not following the Mediterranean diet and intermittent fasting programmes in the last three months,
• • Not being diagnosed with an eating behaviour disorder,
• • Not having any communication problems,
• • Signing the informed consent form,
• • Brain MRI within the last three months,
• • Not to be pregnant and lactating
• • No physical disability No history of cancer
• • Body Mass Index between 18,5 kg/m2- 29,9 kg/m2,
• • Not losing 5% and/or more body weight in the last month
• Exclusion Criteria:
• • Having a diagnosis of autoimmune system disease that may adversely affect working outside of -MS,
• • To be in the attack period-Being under 18 years of age and over 65 years of age
• • Being in menopause-Mediterranean diet and intermittent fasting feeding programmes within the last three months,
• • Diet therapy that has an effect on the autoimmune system within the last three months,
• • Being diagnosed with eating behaviour disorder,
• • Having any communication problems,- Not signing the informed consent form,
• • Failure to adapt to the work during the working period, to be in a situation/behaviour that may adversely affect the work,
• • To have applied any nutritional intervention during the last three months prior to the study,
• • Taking supplements such as selenium, zinc, iron, vitamin D and/or B12, which may affect the course of the study,
• • To have received cancer treatment and / or to be receiving cancer treatment,
• • Other neurological diseases (e.g. Parkinson's, epilepsy, Alzheimer's),
• • Diagnosed with a disease lasting more than 4 months in the last 12 months and other specialised dietary / compositionally different dietary patterns (e.g. high protein, ketogenic, low energy content \< 1000 kcal/day),
• • Body Mass Index \<18.5 kg/m2 or \>30 kg/m2
• • Losing 5% and/or more body weight in the last month,
• • Having a physical disability